Jiumaojiu International Holdings Limited (FRA:3YU)

Intra-Cellular Therapies Revenue

In the year 2024, Jiumaojiu International Holdings had annual revenue of 6.07B CNY with 1.45% growth. Jiumaojiu International Holdings had revenue of 3.01B in the half year ending December 31, 2024, with 42.90% growth.

• Revenue: 6.07B CNY
• Revenue Growth: +1.45%
• P/S Ratio: 0.54
• Revenue / Employee: 292.96K CNY
• Employees: 20,735
• Market Cap: 437.94M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.07B	87.09M	1.45%
Dec 31, 2023	5.99B	1.98B	49.47%
Dec 31, 2022	4.01B	-173.98M	-4.16%
Dec 31, 2021	4.18B	1.46B	53.96%
Dec 31, 2020	2.71B	27.54M	1.02%